
Ashland Expands Injectables Portfolio with High-Purity Sucrose and Low-Nitrite Excipients
Ashland is spotlighting multiple new and optimized pharmaceutical product offerings during CPHI Frankfurt, October 28-30 (booth 8.0Q48) and AAPS PharmSci 360, San Antonio, TX, November 9-12 (booth 2808). To respond to global customer needs, Ashland has introduced vialose™ sucrose, a…












